CGEN (Compugen) Bozor qiymatining balans qiymatiga nisbati

Compugen Ltd (CGEN) kompaniyasining rasmiy ramzlari

Compugen Ltd. (CGEN) o'smalarga qarshi kurashish uchun ilg'or antitanachalar ishlab chiqishga e'tibor qaratadi va sog'liqni saqlash gigantlaridan moliyaviy ko'mak oladi. Ushbu narxlar grafigi joriy bozor kotirovkalarini aks ettiradi, bunda ko'rsatkich 2.01 darajasida turibdi. Biznes modeli ishlab chiqarish va sinovlarni to'liq autsorsing qilishga asoslangan bo'lib, bu ilmiy jamoaga kapital xarajatlarni minimallashtirish va operatsion moslashuvchanlikni saqlab qolish imkonini beradi.

cgen.com (CGEN): Kapitallashuvning balans qiymatiga nisbati 04.07.2022dan 27.10.2026gacha
cgen.com brendining mahsuloti

Compugen Ltd. (CGEN) uchun, uning daromadlari o'zining tijorat mahsuloti yo'qligi sababli litsenziyalash to'lovlariga bog'liq bo'lgani bois, ushbu ko'rsatkich sof aktivlarning haqiqiy qiymati va tadqiqotlar muvaffaqiyatiga oid spekulyativ bozor kutuvlari o'rtasidagi farqni belgilaydi. Market-to-book koeffitsiyentini tahlil qilish orqali investor joriy bozor narxi va balans qiymati o'rtasidagi bog'liqlikni baholaydi, bu esa biznesning haddan tashqari yuqori baholanishini va kapitalning keskin korreksiyasi xavfini aniqlash imkonini beradi.

Raqobatchilar tahlili

Bozor qiymatining balans qiymatiga nisbati ImmunityBio, Inc.|IMCR (immunocore.com) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati JANX (Janux Therapeutics, Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti RCUS|Bozor qiymatining balans qiymatiga nisbati Zymeworks Corp ZYME|Kapitallashuvning balans qiymatiga nisbati Tango Therapeutics Corp (TNGX)|Iovance Biotherapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|immatics.com - Kapitallashuvning sof aktivlarga nisbati|XNCR (Xencor) - Bozor qiymatining balans qiymatiga nisbati|CMPX: Bozor qiymatining balans qiymatiga koeffitsiyenti|Replimune Corp (REPL) - Bozor qiymatining balans qiymatiga nisbati|LYEL (Lyell Pharma) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati IPHA (Innate Pharma S.A.)|Bozor qiymatining balans qiymatiga koeffitsiyenti Pyxis|IOBT: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati Sutro Biopharma Inc. STRO|INKT: Kapitallashuvning sof aktivlarga nisbati|HOWL - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Immix (IMMX)|ALXO - Balans qiymatiga nisbatan bozor qiymati|Cue Biopharma - Bozor kapitallashuvining balans qiymatiga nisbati|PDSB (PDS Biotechnology Corporation) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati SONN|Kapitallashuvning sof aktivlarga nisbati MAIA|Bozor qiymatining balans qiymatiga nisbati LIMN (Liminatus Pharma)|Kapitallashuvning sof aktivlarga nisbati lavatherapeutics.com LVTX|Kapitallashuvning sof aktivlarga nisbati NXTC (NextCure)|Leap Therapeutics Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Intensity Tx (INTS) - Bozor qiymatining balans qiymatiga nisbati|SNSE: Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati TOVX|Bozor qiymatining balans qiymatiga koeffitsiyenti Gritstone bio|Kineta - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining xususiy kapitalga nisbati NexImmune Inc (NEXI)|Kapitallashuvning sof aktivlarga nisbati Turnstone Biologics|Bozor kapitallashuvining balans qiymatiga multiplikatori Vaccinex Inc (VCNX)|Bozor kapitallashuvining balans qiymatiga nisbati Harpoon Therapeutics